{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:04:38Z","timestamp":1784088278264,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangdong Provincial Clinical Research Center for Laboratory Medicine","award":["2023B110008"],"award-info":[{"award-number":["2023B110008"]}]},{"name":"the International Collaborative Project of Shenzhen Science and Technology program","award":["GJHZ20220913144213025"],"award-info":[{"award-number":["GJHZ20220913144213025"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772921"],"award-info":[{"award-number":["81772921"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Planning Project of Shenzhen Municipality","award":["JCYJ20240811001945001,JCYJ20230807142806014"],"award-info":[{"award-number":["JCYJ20240811001945001,JCYJ20230807142806014"]}]},{"name":"the Shenzhen Key Medical Discipline","award":["SZXK054"],"award-info":[{"award-number":["SZXK054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16208-7","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T08:25:38Z","timestamp":1779438338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of CNTNAP2\/PAX1 hypermethylation as an epigenetic biomarker panel for detection of cervical cancer and precancerous lesions in hrHPV-positive women"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"16208_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in Women: Burden and Trends. Cancer Epidemiol Biomarkers Prev. 2017;26:444\u201357. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0858.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"16208_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191\u2013203. https:\/\/doi.org\/10.1016\/S2214-109X(19)30482-6.","journal-title":"Lancet Glob Health"},{"key":"16208_CR3","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11:e197\u2013206. https:\/\/doi.org\/10.1016\/S2214-109X(22)00501-0.","journal-title":"Lancet Glob Health"},{"key":"16208_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23280","volume":"23","author":"C Gilham","year":"2019","unstructured":"Gilham C, Sargent A, Kitchener HC, Peto J. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Health Technol Assess. 2019;23:1\u201344. https:\/\/doi.org\/10.3310\/hta23280.","journal-title":"Health Technol Assess"},{"key":"16208_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"M-H Mayrand","year":"2007","unstructured":"Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579\u201388. https:\/\/doi.org\/10.1056\/NEJMoa071430.","journal-title":"N Engl J Med"},{"key":"16208_CR6","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/S0140-6736(11)61522-5","volume":"378","author":"E Lazcano-Ponce","year":"2011","unstructured":"Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmer\u00f3n J, Uribe P, Velasco-Mondrag\u00f3n E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378:1868\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(11)61522-5.","journal-title":"Lancet"},{"key":"16208_CR7","doi-asserted-by":"publisher","first-page":"101143","DOI":"10.1016\/j.xcrm.2023.101143","volume":"4","author":"P Zhu","year":"2023","unstructured":"Zhu P, Xiong J, Yuan D, Li X, Luo L, Huang J, et al. ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection. Cell Rep Med. 2023;4:101143. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101143.","journal-title":"Cell Rep Med"},{"key":"16208_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41416-021-01614-4","volume":"126","author":"S Dick","year":"2022","unstructured":"Dick S, Vink FJ, Heideman DAM, Lissenberg-Witte BI, Meijer CJLM, Berkhof J. Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4\/miR124-2 methylation and HPV genotyping. Br J Cancer. 2022;126:259\u201364. https:\/\/doi.org\/10.1038\/s41416-021-01614-4.","journal-title":"Br J Cancer"},{"key":"16208_CR9","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1038\/s41591-024-03014-6","volume":"30","author":"L Schreiberhuber","year":"2024","unstructured":"Schreiberhuber L, Barrett JE, Wang J, Redl E, Herzog C, Vavourakis CD, et al. Cervical cancer screening using DNA methylation triage in a real-world population. Nat Med. 2024;30:2251\u20137. https:\/\/doi.org\/10.1038\/s41591-024-03014-6.","journal-title":"Nat Med"},{"key":"16208_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ijc.34686","volume":"154","author":"M El-Zein","year":"2024","unstructured":"El-Zein M, Cheishvili D, Szyf M, Franco EL. Validation of novel DNA methylation markers in cervical precancer and cancer. Int J Cancer. 2024;154:104\u201313. https:\/\/doi.org\/10.1002\/ijc.34686.","journal-title":"Int J Cancer"},{"key":"16208_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ijc.30781","volume":"141","author":"MA Clarke","year":"2017","unstructured":"Clarke MA, Luhn P, Gage JC, Bodelon C, Dunn ST, Walker J, et al. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer. Int J Cancer. 2017;141:701\u201310. https:\/\/doi.org\/10.1002\/ijc.30781.","journal-title":"Int J Cancer"},{"key":"16208_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ijc.34504","volume":"153","author":"BMM Wever","year":"2023","unstructured":"Wever BMM, van den Helder R, van Splunter AP, van Gent MDJM, Kasius JC, Trum JW, et al. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes. Int J Cancer. 2023;153:341\u201351. https:\/\/doi.org\/10.1002\/ijc.34504.","journal-title":"Int J Cancer"},{"key":"16208_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-62703-011-3_12","volume":"925","author":"SA Smallwood","year":"2012","unstructured":"Smallwood SA, Kelsey G. Genome-wide analysis of DNA methylation in low cell numbers by reduced representation bisulfite sequencing. Methods Mol Biol. 2012;925:187\u201397. https:\/\/doi.org\/10.1007\/978-1-62703-011-3_12.","journal-title":"Methods Mol Biol"},{"key":"16208_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","volume":"24","author":"Y-Y Kan","year":"2014","unstructured":"Kan Y-Y, Liou Y-L, Wang H-J, Chen C-Y, Sung L-C, Chang C-F, et al. PAX1 methylation as a potential biomarker for cervical cancer screening. Int J Gynecol Cancer. 2014;24:928\u201334. https:\/\/doi.org\/10.1097\/IGC.0000000000000155.","journal-title":"Int J Gynecol Cancer"},{"key":"16208_CR15","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/sim.2677","volume":"26","author":"ND Mercaldo","year":"2007","unstructured":"Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26:2170\u201383. https:\/\/doi.org\/10.1002\/sim.2677.","journal-title":"Stat Med"},{"key":"16208_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4161\/cbt.7.7.6208","volume":"7","author":"N Omura","year":"2008","unstructured":"Omura N, Li C-P, Li A, Hong S-M, Walter K, Jimeno A, et al. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther. 2008;7:1146\u201356. https:\/\/doi.org\/10.4161\/cbt.7.7.6208.","journal-title":"Cancer Biol Ther"},{"key":"16208_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cas.12352","volume":"105","author":"J Takita","year":"2014","unstructured":"Takita J, Chen Y, Kato M, Ohki K, Sato Y, Ohta S, et al. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays. Cancer Sci. 2014;105:258\u201364. https:\/\/doi.org\/10.1111\/cas.12352.","journal-title":"Cancer Sci"},{"key":"16208_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0179-x","volume":"50","author":"H-J Kim","year":"2018","unstructured":"Kim H-J, Kang T-W, Haam K, Kim M, Kim S-K, Kim S-Y, et al. Whole genome MBD-seq and RRBS analyses reveal that hypermethylation of gastrointestinal hormone receptors is associated with gastric carcinogenesis. Exp Mol Med. 2018;50:1\u201314. https:\/\/doi.org\/10.1038\/s12276-018-0179-x.","journal-title":"Exp Mol Med"},{"key":"16208_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13148-023-01509-6","volume":"15","author":"FF-L Chung","year":"2023","unstructured":"Chung FF-L, Maldonado SG, Nemc A, Bouaoun L, Cahais V, Cuenin C, et al. Buffy coat signatures of breast cancer risk in a prospective cohort study. Clin Epigenetics. 2023;15:102. https:\/\/doi.org\/10.1186\/s13148-023-01509-6.","journal-title":"Clin Epigenetics"},{"key":"16208_CR20","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.7150\/thno.58385","volume":"11","author":"X Sun","year":"2021","unstructured":"Sun X, Yi J, Yang J, Han Y, Qian X, Liu Y, et al. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance. Theranostics. 2021;11:5346\u201364. https:\/\/doi.org\/10.7150\/thno.58385.","journal-title":"Theranostics"},{"key":"16208_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40170-024-00370-2","volume":"12","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yu P, Wang Y, Li H, Qiao H, Sun C, et al. Silencing of STEAP3 suppresses cervical cancer cell proliferation and migration via JAK\/STAT3 signaling pathway. Cancer Metab. 2024;12:40. https:\/\/doi.org\/10.1186\/s40170-024-00370-2.","journal-title":"Cancer Metab"},{"key":"16208_CR22","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1016\/j.ygeno.2020.07.032","volume":"112","author":"Y Liu","year":"2020","unstructured":"Liu Y, Han Y, Zhou L, Pan X, Sun X, Liu Y, et al. A comprehensive evaluation of computational tools to identify differential methylation regions using RRBS data. Genomics. 2020;112:4567\u201376. https:\/\/doi.org\/10.1016\/j.ygeno.2020.07.032.","journal-title":"Genomics"},{"key":"16208_CR23","doi-asserted-by":"publisher","first-page":"e12108","DOI":"10.1097\/MD.0000000000012108","volume":"97","author":"M Yuan","year":"2018","unstructured":"Yuan M, Yuan J, Mei L, Abulizi G. Bioinformatics analysis of methylation in cervical adenocarcinoma in Xinjiang. China Med (Baltimore). 2018;97:e12108. https:\/\/doi.org\/10.1097\/MD.0000000000012108.","journal-title":"China Med (Baltimore)"},{"key":"16208_CR24","doi-asserted-by":"publisher","first-page":"868","DOI":"10.21037\/atm-19-4577","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Nie S, Li S, Meng H, Sun R, Yang J, et al. Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma. Ann Transl Med. 2020;8:868. https:\/\/doi.org\/10.21037\/atm-19-4577.","journal-title":"Ann Transl Med"},{"key":"16208_CR25","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/cncr.26558","volume":"118","author":"JB Kisiel","year":"2012","unstructured":"Kisiel JB, Yab TC, Taylor WR, Chari ST, Petersen GM, Mahoney DW, et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer. 2012;118:2623\u201331. https:\/\/doi.org\/10.1002\/cncr.26558.","journal-title":"Cancer"},{"key":"16208_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/1471-2407-14-324","volume":"14","author":"TZ Parris","year":"2014","unstructured":"Parris TZ, Aziz L, Kov\u00e1cs A, Hajizadeh S, Nemes S, Semaan M, et al. Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer. 2014;14:324. https:\/\/doi.org\/10.1186\/1471-2407-14-324.","journal-title":"BMC Cancer"},{"key":"16208_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/genes11111272","volume":"11","author":"L Brignoni","year":"2020","unstructured":"Brignoni L, Cappetta M, Colistro V, Sans M, Artagaveytia N, Bonilla C, et al. Genomic Diversity in Sporadic Breast Cancer in a Latin American Population. Genes (Basel). 2020;11:1272. https:\/\/doi.org\/10.3390\/genes11111272.","journal-title":"Genes (Basel)"},{"key":"16208_CR28","doi-asserted-by":"publisher","first-page":"14083","DOI":"10.1038\/s41598-022-14977-2","volume":"12","author":"KJ Rautajoki","year":"2022","unstructured":"Rautajoki KJ, Jaatinen S, Tiihonen AM, Annala M, Vuorinen EM, Kivinen A, et al. PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas. Sci Rep. 2022;12:14083. https:\/\/doi.org\/10.1038\/s41598-022-14977-2.","journal-title":"Sci Rep"},{"key":"16208_CR29","doi-asserted-by":"publisher","first-page":"17290","DOI":"10.1073\/pnas.1413204111","volume":"111","author":"AM Mabb","year":"2014","unstructured":"Mabb AM, Kullmann PHM, Twomey MA, Miriyala J, Philpot BD, Zylka MJ. Topoisomerase 1 inhibition reversibly impairs synaptic function. Proc Natl Acad Sci U S A. 2014;111:17290\u20135. https:\/\/doi.org\/10.1073\/pnas.1413204111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16208_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.4149\/neo_2022_220106N25","volume":"69","author":"BDS Passaia","year":"2022","unstructured":"Passaia BDS, Kremer JL, Fragoso MCV, Lotfi CFP. N-type calcium channel v2.2 is a target of TCF21 in adrenocortical carcinomas. Neoplasma. 2022;69:899\u2013908. https:\/\/doi.org\/10.4149\/neo_2022_220106N25.","journal-title":"Neoplasma"},{"key":"16208_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2005.06.049","volume":"232","author":"DI Smith","year":"2006","unstructured":"Smith DI, Zhu Y, McAvoy S, Kuhn R. Common fragile sites, extremely large genes, neural development and cancer. Cancer Lett. 2006;232:48\u201357. https:\/\/doi.org\/10.1016\/j.canlet.2005.06.049.","journal-title":"Cancer Lett"},{"key":"16208_CR32","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.oraloncology.2012.03.007","volume":"48","author":"R Bhatnagar","year":"2012","unstructured":"Bhatnagar R, Dabholkar J, Saranath D. Genome-wide disease association study in chewing tobacco associated oral cancers. Oral Oncol. 2012;48:831\u20135. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.03.007.","journal-title":"Oral Oncol"},{"key":"16208_CR33","doi-asserted-by":"publisher","first-page":"qzae052","DOI":"10.1093\/gpbjnl\/qzae052","volume":"22","author":"Y Lin","year":"2024","unstructured":"Lin Y, Li J, Liang S, Chen Y, Li Y, Cun Y, et al. Pan-cancer Analysis Reveals m6A Variation and Cell-specific Regulatory Network in Different Cancer Types. Genomics Proteom Bioinf. 2024;22:qzae052. https:\/\/doi.org\/10.1093\/gpbjnl\/qzae052.","journal-title":"Genomics Proteom Bioinf"},{"key":"16208_CR34","doi-asserted-by":"publisher","unstructured":"Lin Y, Xu X, Liu Z, Chen H, Bao Y, Meng J, et al. Pan-Cancer Analysis for Identification of Tumor Antigens and Immune Subtypes in mRNA Vaccine Development. iC. 2024;1. https:\/\/doi.org\/10.71373\/FEHU5094.","DOI":"10.71373\/FEHU5094"},{"key":"16208_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1186\/s12885-024-12696-7","volume":"24","author":"M Huang","year":"2024","unstructured":"Huang M, Wang T, Li M, Qin M, Deng S, Chen D. Evaluating PAX1 methylation for cervical cancer screening triage in non-16\/18 hrHPV-positive women. BMC Cancer. 2024;24:913. https:\/\/doi.org\/10.1186\/s12885-024-12696-7.","journal-title":"BMC Cancer"},{"key":"16208_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/ijc.30534","volume":"140","author":"A Kocsis","year":"2017","unstructured":"Kocsis A, Tak\u00e1cs T, Jeney C, Schaff Z, Koiss R, J\u00e1ray B, et al. Performance of a new HPV and biomarker assay in the management of hrHPV positive women: Subanalysis of the ongoing multicenter TRACE clinical trial (n\u2009>\u20096,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int J Cancer. 2017;140:1119\u201333. https:\/\/doi.org\/10.1002\/ijc.30534.","journal-title":"Int J Cancer"},{"key":"16208_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.33820","volume":"150","author":"L Verhoef","year":"2022","unstructured":"Verhoef L, Bleeker MCG, Polman N, Steenbergen RDM, Meijer CJLM, Melchers WJG, et al. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort. Int J Cancer. 2022;150:440\u20139. https:\/\/doi.org\/10.1002\/ijc.33820.","journal-title":"Int J Cancer"},{"key":"16208_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","volume":"9","author":"M Schmitz","year":"2017","unstructured":"Schmitz M, Wunsch K, Hoyer H, Scheungraber C, Runnebaum IB, Hansel A, et al. Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women. Clin Epigenetics. 2017;9:118. https:\/\/doi.org\/10.1186\/s13148-017-0419-2.","journal-title":"Clin Epigenetics"},{"key":"16208_CR39","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1186\/s12885-025-14531-z","volume":"25","author":"Y Ren","year":"2025","unstructured":"Ren Y, Qin F, Shen L, Li L, Wu Q, Yi P. Triage of women with a positive HPV DNA test: evaluating a DNA methylation panel for detecting cervical intraepithelial neoplasia grade 3 and cervical cancer in cervical cytology samples. BMC Cancer. 2025;25:1207. https:\/\/doi.org\/10.1186\/s12885-025-14531-z.","journal-title":"BMC Cancer"},{"key":"16208_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13148-015-0122-0","volume":"7","author":"PB Pun","year":"2015","unstructured":"Pun PB, Liao Y-P, Su P-H, Wang H-C, Chen Y-C, Hsu Y-W, et al. Triage of high-risk human papillomavirus-positive women by methylated POU4F3. Clin Epigenetics. 2015;7:85. https:\/\/doi.org\/10.1186\/s13148-015-0122-0.","journal-title":"Clin Epigenetics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16208-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16208-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:12:22Z","timestamp":1784085142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16208-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16208"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16208-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of Shenzhen Luohu People's Hospital.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"847"}}